{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:58:28Z","timestamp":1790539108796,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.transci.2026.104531","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T08:58:46Z","timestamp":1789721926000},"page":"104531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fondaparinux versus regional citrate anticoagulation in artificial liver support for patients with liver failure and high bleeding risk: A pilot randomized controlled trial"],"prefix":"10.1016","volume":"65","author":[{"given":"Lanzhen","family":"Zeng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.transci.2026.104531_bib1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00467-020-04613-4","article-title":"Extracorporeal renal and liver support in pediatric acute liver failure","volume":"36","author":"Zoica","year":"2021","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.transci.2026.104531_bib2","unstructured":"Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association, & Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association (2025). Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 33(1), 18\u201333."},{"issue":"1","key":"10.1016\/j.transci.2026.104531_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial","volume":"64","author":"Larsen","year":"2016","journal-title":"J Hepatol"},{"issue":"3","key":"10.1016\/j.transci.2026.104531_bib4","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/jca.21873","article-title":"Initial experience with high-volume plasma exchange in patients with acute liver failure","volume":"36","author":"Kim","year":"2021","journal-title":"J Clin Apher"},{"issue":"5","key":"10.1016\/j.transci.2026.104531_bib5","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12664-025-01742-2","article-title":"Role of therapeutic plasma exchange on survival in pediatric acute liver failure and acute-on chronic liver failure: a systematic review and meta-analysis","volume":"44","author":"Panda","year":"2025","journal-title":"Indian J Gastroenterol"},{"issue":"8","key":"10.1016\/j.transci.2026.104531_bib6","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1007\/s00431-024-05587-3","article-title":"Continuous renal replacement therapy and therapeutic plasma exchange in pediatric liver failure","volume":"183","author":"Jackson","year":"2024","journal-title":"Eur J Pediatr"},{"issue":"2","key":"10.1016\/j.transci.2026.104531_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.transci.2018.02.001","article-title":"Therapeutic plasma exchange: a prospective randomized trial to evaluate 2 strategies in patients with liver failure","volume":"57","author":"Yuan","year":"2018","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2026.104531_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1031796","article-title":"Regional citrate anticoagulation for replacement therapy in patients with liver failure: a systematic review and meta-analysis","volume":"10","author":"Peng","year":"2023","journal-title":"Front Nutr"},{"issue":"2","key":"10.1016\/j.transci.2026.104531_bib9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2215\/CJN.0000000000000351","article-title":"Regional citrate anticoagulation versus no anticoagulation for CKRT in patients with liver failure with increased bleeding risk","volume":"19","author":"Bai","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.transci.2026.104531_bib10","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1159\/000548073","article-title":"Application of predilution plasma exchange: a new plasmapheresis method for self-anticoagulation, in liver failure","volume":"54","author":"Liu","year":"2025","journal-title":"Blood Purif"},{"key":"10.1016\/j.transci.2026.104531_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2023.1206999","article-title":"Clinical application of regional citrate anticoagulation for membrane-based therapeutic plasma exchange in children with liver failure","volume":"11","author":"Hu","year":"2023","journal-title":"Front Pediatr"},{"issue":"1","key":"10.1016\/j.transci.2026.104531_bib12","first-page":"1","article-title":"Anticoagulation strategies for continuous renal replacement therapy in France: a survey of practices","volume":"54","author":"Pible","year":"2025","journal-title":"Blood Purif"},{"issue":"12","key":"10.1016\/j.transci.2026.104531_bib13","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00228-025-03913-8","article-title":"Safety and efficacy of fondaparinux use in hemodialysis patients with heparin-induced thrombocytopenia: a systematic review","volume":"81","author":"Stojadinovic","year":"2025","journal-title":"Eur J Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.transci.2026.104531_bib14","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/aor.12002","article-title":"Anticoagulation with fondaparinux for hemodiafiltration in patients with heparin-induced thrombocytopenia: dose-finding study and safety evaluation","volume":"37","author":"Mahieu","year":"2013","journal-title":"Artif Organs"},{"issue":"1","key":"10.1016\/j.transci.2026.104531_bib15","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40360-023-00643-4","article-title":"Novel fondaparinux protocol for anticoagulation therapy in adults with renal failure and suspected heparin-induced thrombocytopenia: a retrospective review of institutional protocol","volume":"24","author":"Ghaziri","year":"2023","journal-title":"BMC Pharmacol Toxicol"},{"issue":"10489","key":"10.1016\/j.transci.2026.104531_bib16","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/S0140-6736(25)00672-5","article-title":"CONSORT 2025 statement: updated guideline for reporting randomised trials","volume":"405","author":"Hopewell","year":"2025","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.transci.2026.104531_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"11","key":"10.1016\/j.transci.2026.104531_bib18","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1111\/jth.13140","article-title":"Definition of clinically relevant non-major bleeding in studies of anticoagulants in atrial fibrillation and venous thromboembolic disease in non-surgical patients: communication from the SSC of the ISTH","volume":"13","author":"Kaatz","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.transci.2026.104531_bib19","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226001631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:49:32Z","timestamp":1790538572000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226001631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1473050226001631"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104531","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fondaparinux versus regional citrate anticoagulation in artificial liver support for patients with liver failure and high bleeding risk: A pilot randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104531","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"104531"}}